secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001819790-24-000004
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus publishes corporate presentation; no specific financial details available
--------------------------------------------------------------------------------

- Tarsus published a corporate presentation on its website on January 8, 2024.
- Presentation includes a patient case for XDEMVY (Sulma).
- No financial results or guidance disclosed in the available excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000004/0001819790-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000004/tars-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001819790-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer